Chau Cheng
Contatto Relazioni con gli Investitori presso IMMUNOVANT, INC.
Profilo
Chau Cheng is currently the Vice President-Investor Relations at Immunovant, Inc. Prior to this, Dr. Cheng held the position of Senior Director-Investor Relations at Immunomedics, Inc. from 2004 to 2020.
Dr. Cheng also served as the VP-Investor Relations & Corporate Communications at CytomX Therapeutics, Inc. from 2020 to 2022.
Dr. Cheng holds an MBA from The Leonard N Stern School of Business, an undergraduate degree from the University of Bradford, and a doctorate from The Open University.
Posizioni attive di Chau Cheng
| Società | Posizione | Inizio |
|---|---|---|
| IMMUNOVANT, INC. | Contatto Relazioni con gli Investitori | - |
Precedenti posizioni note di Chau Cheng
| Società | Posizione | Fine |
|---|---|---|
| CYTOMX THERAPEUTICS, INC. | Contatto Relazioni con gli Investitori | 01/09/2022 |
| IMMUNOMEDICS, INC. | Contatto Relazioni con gli Investitori | 01/12/2020 |
Formazione di Chau Cheng
| The Leonard N Stern School of Business | Masters Business Admin |
| University of Bradford | Undergraduate Degree |
| The Open University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| CYTOMX THERAPEUTICS, INC. | Health Technology |
| IMMUNOVANT, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
- Borsa valori
- Insiders
- Chau Cheng
